You are here


Coverage of the latest news and updates from the field of stem cells and regenerative medicine.

July 13, 2020

OSAKA (JP), July 2020 — Mesenchymal stem cells (MSCs) have the potential to differentiate into a range of different cell types, including bone, fat and muscle cells.

July 9, 2020

MADRID (SP), July 2020 — Stem cells have been holding great promise for regenerative medicine for years.

July 9, 2020

LOS ANGELES, CA (US), July 2020 — A new study shows that SARS-CoV-2, the virus that causes COVID-19, can infect heart cells in a lab dish, indicating it may be possible for heart cells in COVID-19 patients to be directly infected by the virus.

July 6, 2020

LOS ANGELES, CA (US), July 2020 — Scientists from the University of Southern California stem cell laboratories of Neil Segil, Ph.D., and Justin Ichida, Ph.D., are whispering the secrets of a simpl

July 6, 2020

TOKYO (JP), July 2020 — Hematopoiesis can be affected by biological stresses, such as infection, inflammation and certain medications.

July 2, 2020

LEXINGTON, MA (US), June 2020 — Partner Therapeutics, a commercial biotechnology company, has enrolled the first patient dosed in a Phase II study evaluating the efficacy and safety of Leukine® (s

June 29, 2020

COLLEGE STATION, TX (US), June 2020 — Although most broken bones can be mended with a firm cast and a generous measure of tender loving care, more complicated fractures require treatments like bone grafting.

June 29, 2020

BASEL (CH), June 2020 — Protocols that allow the transformation of human induced pluripotent stem cell (iPSC) lines into organoids have changed the way scientists can study developmental processes and enable them to

June 29, 2020

OAKLAND, CA (US) – The governing board of the California Institute for Regenerative Medicine (CIRM) recently awarded $750,000 to Xiaokui Zhang, Ph.D., at Celularity to conduct a clinical trial for the treatment

June 25, 2020

MELBOURNE (AU), June 2020 — Researchers at Children's Cancer Institute have discovered what could prove a new and improved way to treat the poor-prognosis blood cancer, acute myeloid leukemia or AML.